Loading...
Perrigo Company plc
PRGO•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$28.43
$0.32(1.14%)
Perrigo Company plc (PRGO) Financial Performance & Income Statement Overview
Review Perrigo Company plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-6.06%
↓ 6.06%
Operating Income Growth
-25.67%
↓ 25.67%
Net Income Growth
-1252.76%
↓ 1252.76%
Operating Cash Flow Growth
-10.51%
↓ 10.51%
Operating Margin
7.07%
↑ 7.07%
Gross Margin
36.39%
↑ 36.39%
Net Profit Margin
-4.10%
↓ 4.10%
ROE
-3.99%
↓ 3.99%
ROIC
3.53%
↑ 3.53%
Perrigo Company plc (PRGO) Income Statement & Financial Overview
Review Perrigo Company plc's (PRGO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.14B | $1.09B | $1.07B | $1.08B |
| Cost of Revenue | $752.40M | $683.10M | $670.70M | $724.20M |
| Gross Profit | $385.90M | $404.40M | $395.00M | $358.10M |
| Gross Profit Ratio | $0.34 | $0.37 | $0.37 | $0.33 |
| R&D Expenses | $27.90M | $26.00M | $29.40M | $29.00M |
| SG&A Expenses | $234.80M | $271.50M | $300.80M | $305.60M |
| Operating Expenses | $271.70M | $324.00M | $330.20M | $334.60M |
| Total Costs & Expenses | $1.02B | $1.007B | $1.001B | $1.06B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $43.10M | $57.60M | $44.10M | $43.00M |
| Depreciation & Amortization | $900000.00 | -$1.00M | $81.90M | $81.40M |
| EBITDA | $114.20M | $79.40M | $67.40M | $40.90M |
| EBITDA Ratio | $0.10 | $0.07 | $0.06 | $0.04 |
| Operating Income | $114.20M | $80.40M | $64.80M | $23.50M |
| Operating Income Ratio | $0.10 | $0.07 | $0.06 | $0.02 |
| Other Income/Expenses (Net) | -$44.20M | -$58.60M | -$47.50M | -$43.40M |
| Income Before Tax | $70.00M | $21.80M | -$74.00M | -$98.60M |
| Income Before Tax Ratio | $0.06 | $0.02 | -$0.07 | -$0.09 |
| Income Tax Expense | $111.50M | $39.40M | $31.70M | -$102.70M |
| Net Income | -$44.50M | -$21.00M | -$105.70M | $4.10M |
| Net Income Ratio | -$0.04 | -$0.02 | -$0.10 | $0.004 |
| EPS | -$0.32 | -$0.15 | -$0.77 | $0.03 |
| Diluted EPS | -$0.32 | -$0.15 | -$0.77 | $0.03 |
| Weighted Avg Shares Outstanding | $137.60M | $137.50M | $137.10M | $136.60M |
| Weighted Avg Shares Outstanding (Diluted) | $137.60M | $137.50M | $137.10M | $137.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan